Pharma News, 2025

Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting

Myeloma treatment HDP-101 put on FDA fast track

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Tylenol (paracetamol) fights autism claims, slams proposed FDA warning label as 'unsupported' by science

Cullinan Therapeutics showcases preclinical data for autoimmune drug CLN-978

Eli Lilly’s Ebglyss shows sustained skin clearance in atopic dermatitis trial

Ventus and Genentech partner for small-molecule medicine discovery

Acquisition strengthens Aspire Pharma’s strategic portfolio

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn.

NanoViricides reports antiviral activity of NV-387 against measles in preclinical studies

Health Canada conditionally approves Gilead Sciences’ Lyvdelzi for PBC

The US Food and Drug Administration (FDA) has granted approval for Roche’s Gazyva/ Gazyvaro (obinutuzumab) to treat adult patients with active lupus nephritis (LN) who are on...